P1191: ANALYSIS OF PERIPHERAL NEUROPATHY USING CLINICIAN- AND PATIENT-REPORTED OUTCOMES IN THE POLARIX STUDY

• M. Trněný,
• L. Fogliatto,
• F. Gardner,
• I. Flinn,
• J.-F. Larouche,
• C. Haioun,
• M. Canales,
• H. Goto,
• R. Hajek,
• G. Salles,
• J. Qiu,
• A. Campinha-Bacote,
• M. Yan,
• R. Kothari,
• G. Man,
• D. Sahin,
• J. Hirata,
• C. Lee,
• H. Tilly,
• C. Flowers

Affiliations

M. Trněný

1 Charles University General Hospital, Prague, Czechia

L. Fogliatto

2 UFRGS, Porto Alegre, Brazil

F. Gardner

3 Florida Cancer Specialists, Cape Coral

I. Flinn

4 Sarah Cannon Research Institute, Nashville, United States of America

J.-F. Larouche

5 CHU de Quebec, Quebec, Canada

C. Haioun

6 Groupe Hospitalier Albert Mondor, Créteil Cedex, France

M. Canales

7 Hospital Universitario La Paz, Madrid, Spain

H. Goto

8 Hokkaido University Hospital, Sapporo, Japan

R. Hajek

9 University of Ostrava, Ostrava, Czechia

G. Salles

10 Memorial Sloan Kettering Cancer Center, New York

J. Qiu

11 Genentech, Inc., South San Francisco, United States of America

A. Campinha-Bacote

11 Genentech, Inc., South San Francisco, United States of America

M. Yan

12 F. Hoffmann-La Roche Ltd, Mississauga, Canada

R. Kothari

11 Genentech, Inc., South San Francisco, United States of America

G. Man

11 Genentech, Inc., South San Francisco, United States of America

D. Sahin

13 F. Hoffmann-La Roche Ltd, Basel, Switzerland

J. Hirata

11 Genentech, Inc., South San Francisco, United States of America

C. Lee

11 Genentech, Inc., South San Francisco, United States of America

H. Tilly

14 Centre Henri Becquerel, Rouen, France

C. Flowers

15 M.D. Anderson Cancer Center, Atlanta, United States of America